Aethlon Medical
AEMD
11 hedge funds and large institutions have $604K invested in Aethlon Medical in 2020 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, reducing their positions, and 3 closing their positions.
38% more capital invested
Capital invested by funds: $437K → $604K (+$167K)
0% more funds holding
Funds holding: 11 → 11 (0)
0% more ownership
Funds ownership: 0% → 0% (0%)
0% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$24.2K |
| 2 |
Jane Street
New York
|
+$24.2K |
| 3 |
TSS
Two Sigma Securities
New York
|
+$18.1K |
| 4 |
SPC
Sigma Planning Corp
Ann Arbor,
Michigan
|
+$6.04K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AA
Ancora Advisors
Cleveland,
Ohio
|
-$46K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$15K |
| 3 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
-$6.04K |
AEMD Hedge Fund Activity: Q2 2020 in Review
11 of the 4,888 institutional investors tracked by Wall St. Rank reported a position in Aethlon Medical (AEMD) for Q2 2020, worth a combined $604K — up 38% from $437K a quarter earlier.
Fund positioning in AEMD was balanced in Q2 2020: 3 funds opened new positions, 3 closed out, 1 added to existing stakes and 0 trimmed.
The largest buyer was Geode Capital Management, opening a new position worth an estimated $24.2K. The largest seller was Ancora Advisors, exiting entirely with an estimated $46K sold.
- 11 institutional investors held Aethlon Medical (AEMD) as of Q2 2020, unchanged from Q1 2020.
- Funds reported $604K of Aethlon Medical stock for Q2 2020, up 38% quarter-over-quarter.
- 3 funds opened new Aethlon Medical positions in Q2 2020 and 3 closed out, a net change of 0 holders.
- The largest Aethlon Medical buyer in Q2 2020 was Geode Capital Management, an estimated $24.2K added.
- The largest Aethlon Medical seller in Q2 2020 was Ancora Advisors, an estimated $46K sold.
Based on aggregated 13F filings for Q2 2020.